Structure Therapeutics GPCR Cash Flow Statement (2022-2026)

NASDAQ GPCR
$22.80 -0.08 (-0.35%)
As of: Oct 21, 2026 · 9:46 AM EDT
Reported Financials

Structure Therapeutics Quarterly Cash Flow Statement

Periods 18 quarters
Latest Jun 2026

Structure Therapeutics reported cash from operations of -$120.11M and free cash flow of -$120.07M for the quarter ended Jun 2026, down 120.2% year over year. This cash flow statement covers 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -13.08M-13.95M-12.42M-11.88M-17.98M-23.28M-23.86M-24.50M-26.04M-26.03M-33.98M-36.48M-46.83M-61.66M-65.71M33.00M-75.97M-106.16M
Depreciation and DepletionDep. & Depletion 0.07M0.06M0.08M0.07M0.07M0.07M0.08M0.08M0.22M0.23M0.27M0.28M0.27M0.29M0.36M0.41M0.58M0.55M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.07M0.06M0.08M0.07M0.07M0.07M0.08M0.08M0.22M0.23M0.27M0.28M0.27M0.29M0.36M0.41M0.58M0.55M
Share-based CompensationStock Comp. 0.62M0.64M0.63M0.62M2.53M1.70M1.86M2.10M2.74M4.20M6.02M5.83M5.92M7.51M7.50M8.07M11.64M12.63M
Deferred Taxes 0.01M0.12M
Other non-cash itemsOther Non-Cash 0.07M-0.03M-0.19M-0.40M-0.26M-1.56M-1.39M-2.12M-2.84M-2.75M-5.71M-5.56M-4.79M-3.78M-2.65M-1.82M-2.60M-2.63M
Change in Working Capital
Change in Account PayablesChange Payables -1.56M1.58M2.27M-0.12M-0.92M1.05M-2.38M1.40M1.82M-4.39M6.30M-0.42M0.69M0.28M8.81M-5.01M-4.97M3.31M
Change in Accured ExpensesChange Accured Exp. 0.54M2.49M-1.54M0.06M-0.56M3.48M6.09M3.15M-3.03M2.18M5.55M3.02M-0.99M3.60M3.88M15.02M-0.13M5.51M
Change in Other Operating AssetsOther Assets Change 0.10M0.89M-0.92M0.29M3.10M-1.74M0.90M1.76M6.63M-0.63M-2.14M2.61M6.04M0.17M2.57M103.25M-87.17M32.72M
Change in Other Operating LiabilitiesOther Liabilities Change -0.07M-0.10M-0.10M-0.08M-0.09M-0.10M-0.06M-0.07M-0.33M-0.45M-0.29M-0.52M-0.46M-0.63M-0.60M-0.60M-0.49M-0.62M
Other Working Capital ChangesOther WC Changes -0.17M-1.00M0.82M-0.38M-3.20M1.64M-0.96M-1.83M-6.96M0.18M1.85M-3.14M-6.50M-0.80M-3.18M-103.85M86.69M-33.34M
Cash from OperationsCash from Ops. -13.52M-10.10M-10.48M-12.03M-20.31M-16.89M-20.56M-21.73M-34.08M-26.39M-19.70M-36.47M-52.23M-54.56M-51.00M-64.42M15.23M-120.12M
Investing Activities
Capital ExpendituresCapex 0.07M-0.05M0.07M0.07M0.82M1.16M0.16M0.43M0.69M0.02M0.31M0.23M1.57M1.50M1.18M-0.04M
Change in Property, Plant and EquipmentChange in PP&E -0.07M0.05M-0.07M-0.07M-0.82M-1.16M-0.16M-0.43M-0.69M-0.02M-0.31M-0.23M-1.57M-1.50M-1.18M0.04M
Purchase of InvestmentsInvestments Purchased 41.65M26.63M45.99M9.19M190.10M-24.26M14.93M236.59M31.92M283.59M254.76M132.25M116.11M88.83M248.82M93.62M647.47M44.63M
Sale and Maturity of InvestmentsInvestments Sold 2.00M10.50M29.40M19.60M141.08M-92.78M45.88M57.00M33.50M79.50M66.40M165.50M150.45M138.00M195.92M146.17M151.70M119.09M
Cash from Investing ActivitiesCash from Investing -39.72M-16.07M-16.66M10.34M-49.02M-68.71M30.13M-180.74M1.42M-204.52M-189.04M33.23M34.03M48.94M-49.32M56.14M-496.95M74.50M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 0.03M172.33M0.18M0.47M300.12M0.76M515.29M-514.18M0.62M0.97M0.52M0.38M97.59M0.87M2.09M
Net Shares Issued and RepurchasedNet Shares Issued 0.03M172.33M0.18M0.47M300.12M0.76M515.29M-514.18M0.62M0.97M0.52M0.38M97.59M0.87M2.09M
Net Equity Issued and RepurchasedNet Equity Issued 0.03M172.33M0.18M0.47M300.12M0.76M515.29M-514.18M0.62M0.97M0.52M0.38M97.59M0.87M2.09M
Other financing activitiesOther financing -1.45M-0.46M-0.29M-0.32M-2.60M-0.48M-18.49M-0.05M-0.59M-1.15M-0.16M-0.46M-1.87M-2.57M-0.04M
Cash from Financing ActivitiesCash from Financing -1.45M31.04M-0.26M-0.32M169.73M-0.30M0.47M281.63M0.70M514.70M-0.76M0.62M0.81M0.52M56.20M704.99M-1.74M2.09M
Additional items
Change in Cash -54.68M4.87M-27.40M-2.00M100.40M-85.90M10.05M79.16M-31.96M283.80M-209.50M-2.62M-17.39M-5.10M-44.11M696.71M-483.46M-43.53M
Ending Cash Balance 50.62M55.49M28.09M26.09M126.49M40.59M50.64M129.79M97.83M381.63M172.13M169.51M152.12M147.02M102.91M799.62M316.17M272.64M
Free Cash FlowFCF -13.58M-10.04M-10.55M-12.10M-20.31M-16.89M-21.38M-22.89M-34.24M-26.82M-20.38M-36.48M-52.54M-54.79M-52.57M-65.91M14.05M-120.07M
Net Cash FlowNCF -54.68M4.87M-27.40M-2.00M100.40M-85.90M10.05M79.16M-31.96M283.80M-209.50M-2.62M-17.39M-5.10M-44.11M696.71M-483.46M-43.53M

Structure Therapeutics Cash Flow Statement API

Pull Structure Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GPCR&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY